Advertisement
Screener

ILLUMINA, INC. (ILMN) Foreign Currency Transaction Gain (Loss), Unrealized

2.1 / 5 stars · 51/120 Roast Me

ILLUMINA, INC. Foreign Currency Transaction Gain (Loss), Unrealized

ILLUMINA, INC. (ILMN) reported Foreign Currency Transaction Gain (Loss), Unrealized of -$22.00 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-16.

Discontinued › Cash Flow › Operating Activities

us-gaap:ForeignCurrencyTransactionGainLossUnrealized · last filed 2024-02-16

  • ILLUMINA, INC. foreign currency transaction gain (loss), unrealized for the quarter ending 2023-12-31 was -$1.00M.
  • ILLUMINA, INC. foreign currency transaction gain (loss), unrealized for the quarter ending 2023-01-01 was $0.00.
  • ILLUMINA, INC. foreign currency transaction gain (loss), unrealized for the quarter ending 2012-12-30 was -$1.09M.
  • ILLUMINA, INC. foreign currency transaction gain (loss), unrealized for the quarter ending 2012-09-30 was $1.59M.
  • ILLUMINA, INC. foreign currency transaction gain (loss), unrealized for fiscal 2023 was -$22.00M.
  • ILLUMINA, INC. foreign currency transaction gain (loss), unrealized for fiscal 2023 was -$1.00M.
  • ILLUMINA, INC. foreign currency transaction gain (loss), unrealized for fiscal 2022 was $0.00.
  • ILLUMINA, INC. foreign currency transaction gain (loss), unrealized for fiscal 2012 was $2.20M.
Period endForeign Currency Transaction Gain (Loss), Unrealized 3 monthForeign Currency Transaction Gain (Loss), Unrealized 6 monthForeign Currency Transaction Gain (Loss), Unrealized 6 month as first filedForeign Currency Transaction Gain (Loss), Unrealized 9 monthForeign Currency Transaction Gain (Loss), Unrealized 9 month as first filedForeign Currency Transaction Gain (Loss), Unrealized 12 monthForeign Currency Transaction Gain (Loss), Unrealized 12 month as first filed
2023-12-31-$1.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-16
-$22.00M
10-K · filed 2024-02-16
2023-10-01-$21.00M
10-Q · filed 2023-11-13
2023-01-01$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-16
-$1.00M
10-K · filed 2024-02-16
2022-10-02-$1.00M
10-Q · filed 2023-11-13
2022-01-02$0.00
10-K · filed 2024-02-16
2012-12-30-$1.09M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-15
$500.00K
derived: sum of 2 quarters · filed 2013-02-15
$3.33M
derived: sum of 3 quarters · filed 2013-02-15
$2.20M
10-K · filed 2013-02-15
2012-09-30$1.59M
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-29
$4.42M
derived: sum of 2 quarters · filed 2012-10-29
$3.29M
10-Q · filed 2012-10-29
$3.18M
derived: sum of 4 quarters · filed 2013-02-15
2012-07-01$2.83M
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-30
$1.70M
10-Q · filed 2012-07-30
$1.59M
derived: sum of 3 quarters · filed 2013-02-15
-$1.53M
derived: sum of 4 quarters · filed 2013-02-15
2012-04-01-$1.13M
10-Q · filed 2012-05-03
-$1.24M
derived: sum of 2 quarters · filed 2013-02-15
-$4.36M
derived: sum of 3 quarters · filed 2013-02-15
-$3.27M
derived: sum of 4 quarters · filed 2013-02-15
2012-01-01-$111.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-15
-$3.23M
derived: sum of 2 quarters · filed 2013-02-15
-$2.14M
derived: sum of 3 quarters · filed 2013-02-15
-$2.00M
10-K · filed 2013-02-15
$2.00M
10-K · filed 2012-02-24
2011-10-02-$3.12M
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-29
-$2.03M
derived: sum of 2 quarters · filed 2012-10-29
-$1.89M
10-Q · filed 2012-10-29
$1.89M
10-Q · filed 2011-11-04
-$1.71M
derived: sum of 4 quarters · filed 2012-10-29
2011-07-03$1.09M
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-30
$1.23M
10-Q · filed 2012-07-30
-$1.23M
10-Q · filed 2011-08-10
$1.41M
derived: sum of 3 quarters · filed 2012-07-30
$5.47M
derived: sum of 4 quarters · filed 2012-07-30
2011-04-03$140.00K
10-Q · filed 2012-05-03
$322.00K
derived: sum of 2 quarters · filed 2012-05-03
$4.38M
derived: sum of 3 quarters · filed 2012-05-03
$2.70M
derived: sum of 4 quarters · filed 2012-05-03
2011-01-02$182.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-24
$4.24M
derived: sum of 2 quarters · filed 2012-02-24
$2.56M
derived: sum of 3 quarters · filed 2012-02-24
-$247.00K
10-K · filed 2012-02-24
2010-10-03$4.05M
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04
$2.38M
derived: sum of 2 quarters · filed 2011-11-04
-$429.00K
10-Q · filed 2011-11-04
$462.00K
derived: sum of 4 quarters · filed 2012-02-24
2010-07-04-$1.68M
derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-10
-$4.48M
10-Q · filed 2011-08-10
-$3.59M
derived: sum of 3 quarters · filed 2012-02-24
2010-04-04-$2.81M
10-Q · filed 2011-05-04
-$1.91M
derived: sum of 2 quarters · filed 2012-02-24
2010-01-03$891.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-24
$3.16M
10-K · filed 2012-02-24
2009-09-27$2.27M
10-Q · filed 2010-11-05

Similar stocks

Stock NameCountryMarket CapPE Ratio
WATERS CORP /DE/ (WAT)United States$42.297B224.28
AGILENT TECHNOLOGIES, INC. (A)United States$48.720B27.14
METTLER TOLEDO INTERNATIONAL INC/ (MTD)$30.436B30.62
REVVITY, INC. (RVTY)United States$16.814B53.44
Avantor, Inc. (AVTR)United States$10.501B-9.72
BRUKER CORP (BRKR)United States$9.706B-128.75
Alamar Biosciences, Inc. (ALMR)United States$2.300B
Cytek Biosciences, Inc. (CTKB)United States$0.744B-7.15
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)United States$0.491B-3.95
908 Devices Inc. (MASS)United States$0.476B-9.53